Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 2Neoplasms 1Mouth Neoplasms 1

Interventions

pembrolizumab 5Cisplatin 3RRx-001 2Injections 2trastuzumab deruxtecan 1gluconic acid 1belinostat 1Zinc 1Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Pemetrexed 1Paclitaxel 1Omeprazole 1Nivolumab 1Indomethacin 1IRX 2 1Fluorouracil 1Drug Therapy 1Cyclophosphamide 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Mouth Neoplasms × Indomethacin × Clear all
NCT00210470 2020-12-11

A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer

Brooklyn ImmunoTherapeutics, LLC

Phase 2 Completed
27 enrolled 16 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡